-
Cempra, Inc. Signs Exclusive License And Development Agreement For Solithromy...
TheStreet.com | 05/13/13 - 04:05 PM EDT
-
Cempra To Present Data On Solithromycin's (CEM-101) Potential Against Urogeni...
TheStreet.com | 04/26/13 - 07:01 PM EDT
-
Cempra, Inc. To Present At 12th Annual Needham Healthcare Conference
TheStreet.com | 04/24/13 - 04:05 PM EDT
-
Cempra, Inc. To Report First Quarter 2013 Financial And Operating Results, An...
TheStreet.com | 04/18/13 - 04:05 PM EDT
-
Cempra, Inc. To Present At Cowen And Company 33rd Annual Health Care Conference
TheStreet.com | 02/26/13 - 04:05 PM EST
-
Cempra, Inc. To Report Fourth Quarter And Full Year 2012 Financial And Operat...
TheStreet.com | 02/21/13 - 04:05 PM EST
-
Grant Awarded To Study Novel Therapies For Muco-Obstructive Diseases Includes...
TheStreet.com | 02/12/13 - 08:00 AM EST
-
Cempra, Inc. To Present At BIO CEO & Investor Conference And Leerink Swann Gl...
TheStreet.com | 02/05/13 - 04:05 PM EST
-
Cempra, Inc. Announces Initiation Of Oral Solithromycin Global Phase 3 Clinic...
TheStreet.com | 12/19/12 - 08:00 AM EST
-
Cempra, Inc. Announces Initiation Of CEM-102 Phase 2 Clinical Trial In Patien...
TheStreet.com | 12/14/12 - 08:00 AM EST
-
Cempra, Inc. To Present At Oppenheimer 23rd Annual Healthcare Conference
TheStreet.com | 12/05/12 - 04:00 PM EST
-
Cempra, Inc. To Present At The Jefferies 2012 Global Healthcare Conference In...
TheStreet.com | 11/09/12 - 08:00 AM EST
-
Cempra, Inc. To Report Third Quarter 2012 Financial And Operating Results, An...
TheStreet.com | 11/01/12 - 08:00 AM EDT
-
Cempra Announces Pricing Of $25 Million Private Placement
TheStreet.com | 10/18/12 - 09:22 PM EDT
-
Cempra, Inc. Continues To Differentiate Solithromycin's Potency And Activity ...
TheStreet.com | 10/17/12 - 08:00 AM EDT
-
Cempra, Inc. Announces Positive Top-Line Results From Solithromycin Phase 2 C...
TheStreet.com | 10/04/12 - 08:00 AM EDT
-
Cempra Inc. Presents Additional Data On The Clinical Profile And Activity Spe...
TheStreet.com | 09/07/12 - 08:00 AM EDT
-
Cempra, Inc. To Present At The NIAID Workshop Bridging The Gap - Overcoming B...
TheStreet.com | 08/06/12 - 04:05 PM EDT
-
Cempra, Inc. To Report Second Quarter 2012 Financial And Operating Results, A...
TheStreet.com | 08/01/12 - 04:05 PM EDT
-
Cempra, Inc. To Present At The Global Technology Community 9th Anti-Infective...
TheStreet.com | 07/06/12 - 04:01 PM EDT
-
Cempra Inc. Doses First Patients In Solithromycin (CEM-101) Phase 2 Trial In ...
TheStreet.com | 06/12/12 - 08:00 AM EDT
-
Cempra, Inc. To Present At The BioCentury Future Leaders Conference
TheStreet.com | 04/13/12 - 08:00 AM EDT
-
Cempra Inc.'s Solithromycin (CEM-101) Demonstrates In Vitro Activity Against ...
TheStreet.com | 03/31/12 - 12:01 AM EDT
-
Cempra Inc. Presents Full Data Set Of Phase 2 Clinical Trial Of CEM-101 (Soli...
TheStreet.com | 03/31/12 - 12:01 AM EDT
-
Cempra, Inc. To Present At The Needham 11th Annual Health Care Conference
TheStreet.com | 03/29/12 - 07:00 AM EDT
-
Cempra, Inc. To Present At The Cowen And Company 32nd Annual Health Care Conf...
TheStreet.com | 02/29/12 - 08:00 AM EST
-
Cempra, Inc. Announces Exercise In Full Of Underwriters' Option To Purchase A...
TheStreet.com | 02/27/12 - 04:01 PM EST
-
Cempra, Inc. Announces Closing Of Initial Public Offering Of Common Stock
TheStreet.com | 02/08/12 - 12:26 PM EST
-
Cempra, Inc. Announces Pricing Of Its Initial Public Offering Of Common Stock
TheStreet.com | 02/03/12 - 09:23 AM EST
-
IPOs: Merrimack, Cempra Under The Microscope
Street Watch | 02/01/12 - 07:00 AM EST
|
|